Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 94

Results For "medicines"

1261 News Found

Veeva Vault CTMS launched at Bristol Myers Squibb
Medical Device | April 21, 2022

Veeva Vault CTMS launched at Bristol Myers Squibb

Bringing together Bristol Myers Squibb and Celgene on one clinical trial management system, company goes live with Vault CTMS in record speed


BDR Pharmaceuticals launch Furmecil to treat advanced gastric cancer
Drug Approval | April 20, 2022

BDR Pharmaceuticals launch Furmecil to treat advanced gastric cancer

The launch is yet another first of its kind innovation in India


SNIPR BIOME initiates first-in-human clinical trial with SNIPR001
Biotech | April 20, 2022

SNIPR BIOME initiates first-in-human clinical trial with SNIPR001

The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut


Intas Pharmaceuticals and Comera Life Sciences announce research collaboration
Biotech | April 19, 2022

Intas Pharmaceuticals and Comera Life Sciences announce research collaboration

Under the terms of the partnership agreement, Comera will develop a differentiated formulation of an Intas product using Comera's innovative proprietary SQore formulation platform


PM Narendra Modi lays down five goals for new WHO Global Centre
News | April 19, 2022

PM Narendra Modi lays down five goals for new WHO Global Centre

Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine


Ministry of Health and Family Welfare (MoHFW) organises Health Mela
Public Health | April 18, 2022

Ministry of Health and Family Welfare (MoHFW) organises Health Mela

These melas serve as platforms to attract thousands of people to avail quality healthcare services along with essential medicines and diagnostic services


Amneal achieves second U.S. biosimilars approval with Alymsys
Drug Approval | April 18, 2022

Amneal achieves second U.S. biosimilars approval with Alymsys

Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022


GSK to acquire Sierra Oncology for US $1.9bn
Biotech | April 18, 2022

GSK to acquire Sierra Oncology for US $1.9bn

Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022


Sandoz launches generic brimonidine tartrate eyedrop in US
Drug Approval | April 15, 2022

Sandoz launches generic brimonidine tartrate eyedrop in US

Ocular hypertension affects over 5% of all adults; the eye does not properly drain fluid, causing eye pressure to build up


HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies
Biotech | April 13, 2022

HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies

Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases